Synthetic Design and Biological Evaluation of New p53-MDM2 Interaction Inhibitors Based on Imidazoline Core.
Bazanov DR, Pervushin NV, Savin EV, Tsymliakov MD, Maksutova AI, Savitskaya VY, Sosonyuk SE, Gracheva YA, Seliverstov MY, Lozinskaya NA, Kopeina GS.
Bazanov DR, et al. Among authors: maksutova ai.
Pharmaceuticals (Basel). 2022 Apr 2;15(4):444. doi: 10.3390/ph15040444.
Pharmaceuticals (Basel). 2022.
PMID: 35455441
Free PMC article.